Skip to content
Home/Companies/Pharma/Akinion Pharmaceuticals
AP

Akinion Pharmaceuticals

Pharma·Sweden·Active·13yr hold

Akinion Pharmaceuticals is a pharma company, headquartered in Sweden.

Entry
2013
Hold
13yr
Status
Active
Est. EV
–

Who owns Akinion Pharmaceuticals?

Akinion Pharmaceuticals is currently owned by Rosetta Capital through Rosetta Capital IV (2013 vintage), since 2013.

Hand-verified · updated 2026-06-30

Rosetta Capital
Investor
Rosetta Capital
Rosetta Capital IV · 2013 · Secondaries

Key facts

HQSweden
SectorPharma
StatusActive

More from Rosetta Capital IV

Other portfolio companies in the same fund.

Aprea Therapeutics
Exited 2019
BiotechSweden· 2013
Axelar
Active
BiotechSweden· 2013
Biosergen
Exited 2021
BiotechSweden· 2013
Clanotech
Active
BiotechSweden· 2013
Dilafor
Active
BiotechSweden· 2013
Inhalation Sciences
Active
MedTechSweden· 2013

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings